Table 2

Patient characteristics of 52 patients treated

Stage
II (>4 mm)4
III39
IV9
Gender
Male/Female34/18
Primary site
Trunk24
Extremity20
Head/neck6
Unknown2
Median age (range)60 (26–77)
Median time in months from complete resection until first vaccine (range)5.7 (2.1–12)